Pirfenidone gel in patients with localized scleroderma: a phase II study

INTRODUCTION: Localized scleroderma is an inflammatory disease in its first stages and a fibrotic process in later stages, principally mediated by the transforming growth factor β. To date, there is no standard treatment. The objective of this study was to determine the effectiveness and safety of 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Castellanos, Marco, Tlacuilo-Parra, Alberto, Sánchez-Enríquez, Sergio, Vélez-Gómez, Ezequiel, Guevara-Gutiérrez, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310025/
https://www.ncbi.nlm.nih.gov/pubmed/25533576
http://dx.doi.org/10.1186/s13075-014-0510-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310025/
https://www.ncbi.nlm.nih.gov/pubmed/25533576
http://dx.doi.org/10.1186/s13075-014-0510-4

Ejemplares similares